{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:10:10Z","timestamp":1751429410179,"version":"3.41.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Autoimmune Hepatitis (AIH) is a chronic inflammatory liver disease characterized by a sustained inflammatory response in the liver, usually associated with abnormalities in the immune system.The purpose of this study was to utilize bibliometric analysis to assess the current state of research on AIH and to predict future research areas and emerging trends.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>In this study, we used bibliometric analysis to comprehensively analyze the literature on Autoimmune Hepatitis (AIH) published during the past two decades. <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Literature from 2003 to 2023 was retrieved from the\u00a0Web of Science Core Collection, the world's leading citation indexing database. Visualization and analysis were performed using VOSviewer 1.6.18 and CiteSpace 6.2.R3 software.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The study covered 6,390 papers by 28,037 authors from 291 institutions in 110 countries. AIH research output grew significantly, peaking in 2023. The US was the top contributor, followed by China and Japan. Notable institutions included the University of London, Mayo Clinic, and King's College Hospital NHS Foundation Trust. AIH research spans medicine, healthcare, clinical sciences, molecular biology, immunology, etc.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>In this paper, we have used bibliometric analysis to systematically review and analyze the research literature on autoimmune hepatitis (AIH) over the past two decades. This comprehensive overview aims to provide scholars dedicated to this field with a clear research lineage and future research directions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41065-025-00477-6","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:10:50Z","timestamp":1751361050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trends and hotspots in autoimmune hepatitis research: based on bibliometric analysis"],"prefix":"10.1186","volume":"162","author":[{"given":"Ruisi","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XiaoYing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YiHeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojuan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junqiu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"477_CR1","doi-asserted-by":"crossref","unstructured":"Autoimmune hepatitis. Nature Reviews. Disease Primers. 2018;4:18018.","DOI":"10.1038\/nrdp.2018.18"},{"issue":"6","key":"477_CR2","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1111\/liv.14062","volume":"39","author":"I Doycheva","year":"2019","unstructured":"Doycheva I, Watt KD, Gulamhusein AF. Autoimmune hepatitis: Current and future therapeutic options. Liver Int. 2019;39(6):1002\u201313.","journal-title":"Liver Int"},{"issue":"8","key":"477_CR3","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1111\/hepr.13342","volume":"49","author":"A Tanaka","year":"2019","unstructured":"Tanaka A, Mori M, Matsumoto K, et al. Increase trend in the prevalence and male-to-female ratio of primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis in japan. Hepatol Res. 2019;49(8):881\u20139.","journal-title":"Hepatol Res"},{"issue":"4","key":"477_CR4","doi-asserted-by":"publisher","first-page":"430","DOI":"10.5009\/gnl19261","volume":"14","author":"A Tanaka","year":"2020","unstructured":"Tanaka A. Autoimmune hepatitis: 2019 update. Gut and Liver. 2020;14(4):430\u20138.","journal-title":"Gut and Liver"},{"issue":"3","key":"477_CR5","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S1089-3261(02)00021-1","volume":"6","author":"KM Boberg","year":"2002","unstructured":"Boberg KM. Prevalence and epidemiology of autoimmune hepatitis. Clin Liver Dis. 2002;6(3):635\u201347.","journal-title":"Clin Liver Dis"},{"issue":"6","key":"477_CR6","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1002\/hep.32591","volume":"76","author":"C Harrington","year":"2022","unstructured":"Harrington C, Krishnan S, Mack CL, et al. Noninvasive biomarkers for the diagnosis and management of autoimmune hepatitis [J]. Hepatology (Baltimore, Md.). 2022;76(6):1862\u201379.","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"6","key":"477_CR7","doi-asserted-by":"publisher","first-page":"e0458","DOI":"10.1097\/HC9.0000000000000458","volume":"8","author":"NS Reau","year":"2024","unstructured":"Reau NS, Lammert CS, Weinberg EM. Autoimmune hepatitis: Current and future therapies. Hepatol Commun. 2024;8(6): e0458.","journal-title":"Hepatol Commun"},{"issue":"3","key":"477_CR8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/S40037-021-00695-4","volume":"11","author":"A Ninkov","year":"2022","unstructured":"Ninkov A, Frank JR, Maggio LA. Bibliometrics: methods for studying academic publishing. Perspect Med Education. 2022;11(3):173\u20136.","journal-title":"Perspect Med Education"},{"key":"477_CR9","doi-asserted-by":"publisher","first-page":"1275792","DOI":"10.3389\/fphar.2023.1275792","volume":"14","author":"S Ai","year":"2023","unstructured":"Ai S, Li Y, Zheng H, et al. Global research trends and hot spots on autophagy and kidney diseases: A bibliometric analysis from 2000 to 2022. Front Pharmacol. 2023;14: 1275792.","journal-title":"Front Pharmacol"},{"key":"477_CR10","doi-asserted-by":"publisher","first-page":"1323115","DOI":"10.3389\/fimmu.2023.1323115","volume":"14","author":"WC Yuan","year":"2023","unstructured":"Yuan WC, Zhang JX, Chen HB, et al. A bibliometric and visual analysis of cancer-associated fibroblasts. Front Immunol. 2023;14: 1323115.","journal-title":"Front Immunol"},{"issue":"1","key":"477_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/hep.22322","volume":"48","author":"EM Hennes","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis[J]. Hepatology (Baltimore, Md.). 2008;48(1):169\u201376.","journal-title":"Hepatology (Baltimore, Md)."},{"issue":"21","key":"477_CR12","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.3748\/wjg.14.3292","volume":"14","author":"IR Mackay","year":"2008","unstructured":"Mackay IR. Historical reflections on autoimmune hepatitis. World J Gastroenterol. 2008;14(21):3292\u2013300.","journal-title":"World J Gastroenterol"},{"key":"477_CR13","doi-asserted-by":"crossref","unstructured":"Wei Y, Li Y, Yan L, \u7b49. Alterations of gut microbiome in autoimmune hepatitis. Gut. 2020;69(3):569\u2013577.","DOI":"10.1136\/gutjnl-2018-317836"},{"issue":"7","key":"477_CR14","doi-asserted-by":"publisher","first-page":"100497","DOI":"10.1016\/j.jhepr.2022.100497","volume":"4","author":"M Hayashi","year":"2022","unstructured":"Hayashi M, Abe K, Fujita M, et al. Circulating complement factor H levels are associated with disease severity and relapse in autoimmune hepatitis. JHEP reports: innovation in hepatology. 2022;4(7): 100497.","journal-title":"JHEP reports: innovation in hepatology"},{"issue":"3","key":"477_CR15","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.jhep.2023.04.033","volume":"79","author":"RJ Andrade","year":"2023","unstructured":"Andrade RJ, Aithal GP, de Boer YS, et al. Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report. J Hepatol. 2023;79(3):853\u201366.","journal-title":"J Hepatol"},{"key":"477_CR16","doi-asserted-by":"crossref","unstructured":"Cl M, D A, Dn A, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases [J]. Hepatology (Baltimore, Md.). 2020;72(2):671\u2013722.","DOI":"10.1002\/hep.31065"},{"issue":"1","key":"477_CR17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1053\/j.gastro.2010.04.053","volume":"139","author":"AJ Czaja","year":"2010","unstructured":"Czaja AJ, Manns MP. Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis. Gastroenterology. 2010;139(1):58-72.e4.","journal-title":"Gastroenterology"},{"issue":"1","key":"477_CR18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/lt.25375","volume":"25","author":"G Stirnimann","year":"2019","unstructured":"Stirnimann G, Ebadi M, Czaja AJ, et al. Recurrent and de novo autoimmune hepatitis. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2019;25(1):152\u201366.","journal-title":"Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society"},{"key":"477_CR19","first-page":"e070201","volume":"380","author":"L Muratori","year":"2023","unstructured":"Muratori L, Lohse AW, Lenzi M. Diagnosis and management of autoimmune hepatitis. BMJ (Clinical research ed). 2023;380: e070201.","journal-title":"BMJ (Clinical research ed)"},{"issue":"2 Suppl 1","key":"477_CR20","doi-asserted-by":"publisher","first-page":"S132","DOI":"10.1002\/hep.21059","volume":"43","author":"MP Manns","year":"2006","unstructured":"Manns MP, Vogel A. Autoimmune hepatitis, from mechanisms to therapy. Hepatology (Baltimore, Md). 2006;43(2 Suppl 1):S132-144.","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"10","key":"477_CR21","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1097\/MCG.0000000000001449","volume":"55","author":"NA Tunio","year":"2021","unstructured":"Tunio NA, Mansoor E, Sheriff MZ, et al. Epidemiology of autoimmune hepatitis (AIH) in the united states between 2014 and 2019: A population-based national study. J Clin Gastroenterol. 2021;55(10):903\u201310.","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"477_CR22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1586\/egh.09.15","volume":"3","author":"AJ Czaja","year":"2009","unstructured":"Czaja AJ. Current and future treatments of autoimmune hepatitis. Expert Rev Gastroenterol Hepatol. 2009;3(3):269\u201391.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"6","key":"477_CR23","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/hep.1840070626","volume":"7","author":"JC Homberg","year":"1987","unstructured":"Homberg JC, Abuaf N, Bernard O, et al. Chronic active hepatitis associated with antiliver\/kidney microsome antibody type 1: A second type of\u201cautoimmune\u201d hepatitis [J]. Hepatology (Baltimore, Md.). 1987;7(6):1333\u20139.","journal-title":"Hepatology (Baltimore, Md)."},{"issue":"6","key":"477_CR24","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.jhep.2009.01.020","volume":"50","author":"P Muratori","year":"2009","unstructured":"Muratori P, Granito A, Quarneti C, et al. Autoimmune hepatitis in italy: The bologna experience. J Hepatol. 2009;50(6):1210\u20138.","journal-title":"J Hepatol"},{"key":"477_CR25","doi-asserted-by":"crossref","unstructured":"Mack CL, Adams D, Assis DN, \u7b49. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases[J]. Hepatology (Baltimore, Md.), 2020;72(2):671\u2013722.","DOI":"10.1002\/hep.31065"},{"issue":"9","key":"477_CR26","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1111\/liv.13724","volume":"38","author":"V Gordon","year":"2018","unstructured":"Gordon V, Adhikary R, Appleby V, et al. Diagnosis, presentation and initial severity of autoimmune hepatitis (AIH) in patients attending 28 hospitals in the UK. Liver International: Official Journal of the International Association for the Study of the Liver. 2018;38(9):1686\u201395.","journal-title":"Liver International: Official Journal of the International Association for the Study of the Liver"},{"key":"477_CR27","doi-asserted-by":"publisher","first-page":"18017","DOI":"10.1038\/nrdp.2018.17","volume":"4","author":"G Mieli-Vergani","year":"2018","unstructured":"Mieli-Vergani G, Vergani D, Czaja AJ, et al. Autoimmune hepatitis. Nat Rev Dis Primers. 2018;4:18017.","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"477_CR28","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/hepr.12931","volume":"47","author":"K Harada","year":"2017","unstructured":"Harada K, Hiep NC, Ohira H. Challenges and difficulties in pathological diagnosis of autoimmune hepatitis. Hepatology Research: The Official Journal of the Japan Society of Hepatology. 2017;47(10):963\u201371.","journal-title":"Hepatology Research: The Official Journal of the Japan Society of Hepatology"},{"issue":"Suppl 1","key":"477_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00535-010-0303-8","volume":"46","author":"A Lleo","year":"2011","unstructured":"Lleo A, Shimoda S, Ishibashi H, et al. Primary biliary cirrhosis and autoimmune hepatitis: Apotopes and epitopes. J Gastroenterol. 2011;46(Suppl 1):29\u201338.","journal-title":"J Gastroenterol"},{"issue":"3","key":"477_CR30","first-page":"392","volume":"9","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Xu BH, Rodgers B, et al. Characteristics and inpatient outcomes of primary biliary cholangitis and autoimmune hepatitis overlap syndrome. J Clin Transl Hepatol. 2021;9(3):392\u20138.","journal-title":"J Clin Transl Hepatol"},{"issue":"3","key":"477_CR31","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cld.2018.03.010","volume":"22","author":"U To","year":"2018","unstructured":"To U, Silveira M. Overlap syndrome of autoimmune hepatitis and primary biliary cholangitis. Clin Liver Dis. 2018;22(3):603\u201311.","journal-title":"Clin Liver Dis"},{"issue":"3","key":"477_CR32","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/hep.32417","volume":"76","author":"Y Li","year":"2022","unstructured":"Li Y, Sun Y, Liu Y, et al. Genome-wide meta-analysis identifies susceptibility loci for autoimmune hepatitis type 1. Hepatology (Baltimore, Md). 2022;76(3):564\u201375.","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"477_CR33","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev-pathol-020117-043534","volume":"13","author":"GJ Webb","year":"2018","unstructured":"Webb GJ, Hirschfield GM, Krawitt EL, et al. Cellular and molecular mechanisms of autoimmune hepatitis. Annu Rev Pathol. 2018;13:247\u201392.","journal-title":"Annu Rev Pathol"},{"key":"477_CR34","doi-asserted-by":"publisher","first-page":"984083","DOI":"10.3389\/fimmu.2022.984083","volume":"13","author":"N Ahuja","year":"2022","unstructured":"Ahuja N, Singh J, Minz RW, et al. HLA and non-HLA gene polymorphisms in autoimmune hepatitis patients of north Indian adults. Front Immunol. 2022;13: 984083.","journal-title":"Front Immunol"},{"issue":"1","key":"477_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/hep.510310110","volume":"31","author":"K Agarwal","year":"2000","unstructured":"Agarwal K, Czaja AJ, Jones DE, et al. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. Hepatology (Baltimore, Md). 2000;31(1):49\u201353.","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"2","key":"477_CR36","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1053\/j.gastro.2014.04.022","volume":"147","author":"YS de Boer","year":"2014","unstructured":"de Boer YS, van Gerven NMF, Zwiers A, et al. Genome-wide association study identifies variants associated with autoimmune hepatitis type 1. Gastroenterology. 2014;147(2):443-452.e5.","journal-title":"Gastroenterology"},{"issue":"1","key":"477_CR37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3390\/ijms22010199","volume":"22","author":"NY Lee","year":"2020","unstructured":"Lee NY, Suk KT. The role of the gut microbiome in liver cirrhosis treatment. Int J Mol Sci. 2020;22(1): 199.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"477_CR38","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1053\/j.gastro.2020.04.077","volume":"159","author":"DM Chopyk","year":"2020","unstructured":"Chopyk DM, Grakoui A. Contribution of the intestinal microbiome and gut barrier to hepatic disorders. Gastroenterology. 2020;159(3):849\u201363.","journal-title":"Gastroenterology"},{"issue":"12","key":"477_CR39","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1111\/apt.15754","volume":"51","author":"T Liwinski","year":"2020","unstructured":"Liwinski T, Casar C, Ruehlemann MC, et al. A disease-specific decline of the relative abundance of bifidobacterium in patients with autoimmune hepatitis. Aliment Pharmacol Ther. 2020;51(12):1417\u201328.","journal-title":"Aliment Pharmacol Ther"},{"key":"477_CR40","doi-asserted-by":"publisher","first-page":"725390","DOI":"10.3389\/fmed.2021.725390","volume":"8","author":"A Bruneau","year":"2021","unstructured":"Bruneau A, Hundertmark J, Guillot A, et al. Molecular and cellular mediators of the gut-liver axis in the progression of liver diseases. Front Med. 2021;8: 725390.","journal-title":"Front Med"},{"issue":"3","key":"477_CR41","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/gutjnl-2018-317836","volume":"69","author":"Y Wei","year":"2020","unstructured":"Wei Y, Li Y, Yan L, et al. Alterations of gut microbiome in autoimmune hepatitis. Gut. 2020;69(3):569\u201377.","journal-title":"Gut"},{"key":"477_CR42","doi-asserted-by":"publisher","first-page":"947382","DOI":"10.3389\/fcimb.2022.947382","volume":"12","author":"Z Cheng","year":"2022","unstructured":"Cheng Z, Yang L, Chu H. The gut microbiota: A novel player in autoimmune hepatitis. Front Cell Infect Microbiol. 2022;12: 947382.","journal-title":"Front Cell Infect Microbiol"},{"key":"477_CR43","doi-asserted-by":"publisher","first-page":"1337223","DOI":"10.3389\/fcimb.2024.1337223","volume":"14","author":"C Sun","year":"2024","unstructured":"Sun C, Zhu D, Zhu Q, et al. The significance of gut microbiota in the etiology of autoimmune hepatitis: A narrative review. Front Cell Infect Microbiol. 2024;14: 1337223.","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"477_CR44","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/apt.15795","volume":"52","author":"A Granito","year":"2020","unstructured":"Granito A, Muratori P, Muratori L. Editorial: Gut microbiota profile in patients with autoimmune hepatitis-a clue for adjunctive probiotic therapy? Aliment Pharmacol Ther. 2020;52(2):392\u20134.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"477_CR45","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.jhep.2013.10.020","volume":"60","author":"L Gr\u00f8nb\u00e6k","year":"2014","unstructured":"Gr\u00f8nb\u00e6k L, Vilstrup H, Jepsen P. Autoimmune hepatitis in denmark: Incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study. Journal of Hepatology. 2014;60(3):612\u20137.","journal-title":"Journal of Hepatology"},{"issue":"4","key":"477_CR46","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/liv.14051","volume":"39","author":"L Harrison","year":"2019","unstructured":"Harrison L, Gleeson D. Stopping immunosuppressive treatment in autoimmune hepatitis (AIH): Is it justified (and in whom and when)? Liver International: Official Journal of the International Association for the Study of the Liver. 2019;39(4):610\u201320.","journal-title":"Liver International: Official Journal of the International Association for the Study of the Liver"},{"issue":"2","key":"477_CR47","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/MPG.0000000000001801","volume":"66","author":"G Mieli-Vergani","year":"2018","unstructured":"Mieli-Vergani G, Vergani D, Baumann U, et al. Diagnosis and management of pediatric autoimmune liver disease: ESPGHAN hepatology committee position statement. J Pediatr Gastroenterol Nutr. 2018;66(2):345\u201360.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"477_CR48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.5500\/wjt.v12.i3.59","volume":"12","author":"M Harputluoglu","year":"2022","unstructured":"Harputluoglu M, Caliskan AR, Akbulut S. Autoimmune hepatitis and liver transplantation: Indications, and recurrent and de novo autoimmune hepatitis. World J Transplant. 2022;12(3):59\u201364.","journal-title":"World J Transplant"},{"issue":"2","key":"477_CR49","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/hep.31065","volume":"72","author":"CL Mack","year":"2020","unstructured":"Mack CL, Adams D, Assis DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases. Hepatology (Baltimore, Md). 2020;72(2):671\u2013722.","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"5","key":"477_CR50","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/01.mpg.0000235975.75120.38","volume":"43","author":"M Cuarterolo","year":"2006","unstructured":"Cuarterolo M, Ciocca M, Velasco CC, et al. Follow-up of children with autoimmune hepatitis treated with cyclosporine. J Pediatr Gastroenterol Nutr. 2006;43(5):635\u20139.","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00477-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00477-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00477-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T10:05:11Z","timestamp":1751364311000},"score":1,"resource":{"primary":{"URL":"https:\/\/hereditasjournal.biomedcentral.com\/articles\/10.1186\/s41065-025-00477-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["477"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00477-6","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"18 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"115"}}